Clinical Trials Arena August 23, 2024
GlobalData Healthcare

The most frequently utilised guideline for diagnosis was the American Academy of Pediatrics’ Clinical Practice Guideline.

Attention deficit hyperactivity disorder (ADHD) is a clinically heterogeneous disorder whose diagnosis relies on a combination of questionnaires (self, parent or teacher-reported), clinical interviews and, in some cases, neuropsychiatric testing.

Accurate diagnosis of ADHD is important as, if left untreated, it is associated with negative socioeconomic outcomes such as poor scholastic performance, unemployment, criminality and increased risk of developing other mental health conditions such as substance abuse disorder. The results from a GlobalData high-prescriber survey performed in January 2024 suggest that diagnostic trends for ADHD across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) are being shaped...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
Text messages can be ineffective as medication refill reminders
Challenges and Opportunities for Digital Innovation in Clinical Trials
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
New NIH tool uses genAI to connect volunteers with clinical trials
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article